Total planned funding: $514,190,025
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $84,302,505 |
South Africa | $74,915,737 |
Asia Regional Program | $60,346,961 |
Mozambique | $54,755,594 |
Zimbabwe | $38,523,311 |
West Africa Region | $31,609,898 |
Tanzania | $22,097,369 |
Zambia | $16,773,456 |
Vietnam | $13,831,919 |
Botswana | $13,740,637 |
Dominican Republic | $13,350,629 |
Burundi | $12,940,758 |
Kenya | $12,412,422 |
Democratic Republic of the Congo | $12,212,570 |
Malawi | $9,354,859 |
enumerations.Philippines | $6,641,584 |
Ethiopia | $6,596,768 |
Côte d'Ivoire | $5,692,284 |
Lesotho | $5,281,189 |
Eswatini | $5,032,255 |
Papua New Guinea | $3,494,885 |
Uganda | $3,477,378 |
Angola | $2,250,000 |
Rwanda | $1,713,822 |
Haiti | $827,217 |
Western Hemisphere Region | $709,018 |
India | $600,000 |
Namibia | $450,000 |
Indonesia | $255,000 |
Ghana | $0 |
Caribbean Region | $0 |
South Sudan | $0 |
Organizational Types
NGO | $514,190,025 |
Program Areas
Treatment | $157,442,977 |
Care | $129,899,053 |
Prevention | $119,295,283 |
Testing | $65,930,437 |
Governance and Systems | $41,459,981 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $144,263,425 |
HKID: Care: Orphans and Vulnerable Children | $75,316,347 |
HVOP: Sexual Prevention: Other Sexual Prevention | $71,316,575 |
HVCT: Testing: HIV Testing and Counseling | $65,930,437 |
HBHC: Care: Adult Care and Support | $40,401,298 |
OHSS: Health Systems Strengthening | $17,685,315 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,046,735 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $15,850,073 |
HVSI: Strategic Information | $13,532,319 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $12,999,368 |
HLAB: Laboratory Infrastructure | $10,242,347 |
PDTX: Treatment: Pediatric Treatment | $8,097,438 |
PDCS: Care: Pediatric Care and Support | $7,103,514 |
HVTB: Care: TB/HIV | $7,077,894 |
HTXD: Treatment: ARV Drugs | $5,082,114 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,765,340 |
HMIN: Biomedical Prevention: Injection Safety | $258,760 |
HVMS: Management and Operations | $162,294 |
HMBL: Biomedical Prevention: Blood Safety | $58,432 |
Top Partner Programs
FHI 360:
$514,190,025
View countries